Clinical Trials · NCT07249554

Combination Therapy for Alcohol Use Disorder

Not Yet RecruitingPhase 2Semaglutide (Investigational)
Phase
Phase 2
Recruitment status
Not Yet Recruiting
Sponsor
Johns Hopkins University
Enrollment
45
Start date
Nov 2026
Locations
1 site, United States
Primary endpoint
Participant-reported Adverse Events
View Semaglutide compound reference